Huerta C, Rivero E, Rodriguez LA. Incidence and risk factors for psoriasis in the general population. Arch Dermatol. 2007 Dec;143(12):1559-65.
Marton J, Jackel J, Carson R, Rothermel C, Menzin J. Predictors of costs for skin and skin structure infections due to staphylococcus aureus using a managed-care perspective. Poster presented at the 2007 ISPOR 10th Annual European Congress; October 2007. Dublin, Ireland. [abstract] Value Health. 2007 Nov; 10(6):A446.
McKenna SP, Doward LC, Meads DM, Tennant A, Lawton G, Grueger J. Quality of life in infants and children with atopic dermatitis: addressing issues of differential item functioning across countries in multinational clinical trials. Health Qual Life Outcomes. 2007;5(45).
Arana A, Wentworth CE, Conde E. Cancer incidence in patients with and without atopic dermatitis in the United Kingdom. Presented at the 23rd International Conference on Pharmacoepidemiology; 2007.
Arana A, Arellano FM, Wentworth CE. Cancer incidence in patients with and without atopic dermatitis in the United Kingdom. Presented at the Annual Meeting of the Society for Investigative Dermatology; 2007. Previously presented at the 23rd International Conference on Pharmacoepidemiology.
Arellano FM, Wentworth CE, Arana A, Fernández C, Paul CF. Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. J Invest Dermatol. 2007;127(4):808-16.
Arellano FM, Wentworth CE, Conde E, Schlienger R, Fernández-Vidaurre C, Arana A. Incidencia de cáncer en pacientes con y sin atópica dermatitis en Inglaterra. Presented at the VII Jornadas de Farmacovigilancia; 2007.
Hampson NE, Meads DM, McKenna SP, Doward LC, Turk F. Factors influencing quality of life in atopic dermatitis. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 2005. Florence, Italy. [abstract] Value Health. 2005 Nov; 8(6):A149.
Nijsten T, Whalley D, Gelfand J, Margolis D, McKenna SP, Stern RS. The psychometric properties of the psoriasis disability index in United States patients. J Invest Dermatol. 2005 Oct 1;125(4):665-72.
Colman SS, Nixon A, Barrows SM, Taylor TN, Miller T. Qualitative research methods: development of a hyperpigmentation treatment satisfaction with medication questionnaire. Poster presented at the Annual Meeting of the International Society for Quality of Life Research; October 2005.
Stevens KJ, Brazier JE, McKenna SP, Doward LC, Cork MJ. The development of a preference-based measure of health in children with atopic dermatitis. Br J Dermatol. 2005 Aug 1;153(2):372-7.
Meads DM, McKenna SP, Doward LC, Hampson N. Interpreting scores on the Quality of Life Index for Atopic Dermatitis (QoLIAD). Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 2005. Washington, DC. [abstract] Value Health. 2005 May; 8(3):331-2.
McKenna SP, Whalley D, Dewar AL, Erdman RA, Kohlmann T, Niero M, Baro E, Cook SA, Crickx B. International development of the Parents' Index of Quality of Life in Atopic Dermatitis (PIQoL-AD). Qual Life Res. 2005 Feb 1;14(1):231-41.
Cvetkovski RS, Rothman KJ, Olsen J, Mathiesen B, Iversen L, Johansen JD, Agner T. Relation between diagnoses on severity, sick leave and loss of job among patients with occupational hand eczema. Br J Dermatol. 2005 Jan 1;152(1):93-8.